87 related articles for article (PubMed ID: 11362300)
1. Prevention and treatment studies for CMV open.
Treat Rev; 1995; (no 17):5. PubMed ID: 11362300
[TBL] [Abstract][Full Text] [Related]
2. Advances in treatment for cytomegalovirus retinitis.
Bowers M
BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
[TBL] [Abstract][Full Text] [Related]
3. Oral ganciclovir.
Schouten JT
STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
[TBL] [Abstract][Full Text] [Related]
4. Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.
Przepiorka D; Ippoliti C; Panina A; Goodrich J; Giralt S; van Besien K; Mehra R; Deisseroth AB; Andersson B; Luna M
Bone Marrow Transplant; 1994 Apr; 13(4):461-4. PubMed ID: 8019472
[TBL] [Abstract][Full Text] [Related]
5. Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
Bacigalupo A; van Lint MT; Tedone E; Moro F; Sanna MA; Longren M; Trespi G; Frassoni F; Occhini D; Gualandi F
Bone Marrow Transplant; 1994 Jun; 13(6):753-8. PubMed ID: 7920310
[TBL] [Abstract][Full Text] [Related]
6. New developments in the delivery of ganciclovir for cytomegalovirus (CMV retinitis).
Woodward J
STEP Perspect; 1995; 7(2):2-4. PubMed ID: 11362720
[TBL] [Abstract][Full Text] [Related]
7. CMV treatment.
Treat Rev; 1995; (no 19):4. PubMed ID: 11362756
[TBL] [Abstract][Full Text] [Related]
8. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
Ippoliti C; Morgan A; Warkentin D; van Besien K; Mehra R; Khouri I; Giralt S; Gajewski J; Champlin R; Andersson B; Przepiorka D
Bone Marrow Transplant; 1997 Sep; 20(6):491-5. PubMed ID: 9313883
[TBL] [Abstract][Full Text] [Related]
9. Safety of alternating ganciclovir and foscarnet maintenance therapy in human immunodeficiency virus (HIV)-related cytomegalovirus infections. An open-labeled pilot study.
Peters M; Schürmann D; Bergmann F; Grünewald T; Timm H; Pohle HD; Ruf B
Scand J Infect Dis; 1994; 26(1):49-54. PubMed ID: 8191240
[TBL] [Abstract][Full Text] [Related]
10. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
11. Current management of cytomegalovirus disease in patients with AIDS.
Jacobson MA
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
[TBL] [Abstract][Full Text] [Related]
12. Oral ganciclovir approved for CMV.
Common Factor; 1995 Apr; (no 10):21. PubMed ID: 11362347
[TBL] [Abstract][Full Text] [Related]
13. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
[TBL] [Abstract][Full Text] [Related]
14. Management of cytomegalovirus disease.
Danner SA
AIDS; 1995 Dec; 9 Suppl 2():S3-S8. PubMed ID: 8775800
[TBL] [Abstract][Full Text] [Related]
15. [Oral ganciclovir for the prevention of illnesses caused by CMV].
Vianna G
Sidahora; 1995; ():33-4. PubMed ID: 11362479
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
Parente F; Bianchi Porro G
Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
[TBL] [Abstract][Full Text] [Related]
17. Oral ganciclovir approved.
Gold D
GMHC Treat Issues; 1995 Jan; 9(1):10. PubMed ID: 11367376
[TBL] [Abstract][Full Text] [Related]
18. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
[TBL] [Abstract][Full Text] [Related]
19. Guide to CMV management.
Cheng B
PI Perspect; 1996 Apr; (no 18):13-4. PubMed ID: 11363508
[TBL] [Abstract][Full Text] [Related]
20. Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.
Bacigalupo A; Boyd A; Slipper J; Curtis J; Clissold S
Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1249-64. PubMed ID: 23167560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
